Mitsubishi UFJ Trust & Banking’s Collegium Pharmaceutical COLL Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$794K	Buy	+21,928	New	+$749K	﹤0.01%	922

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's COLL Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking opened a new position in Collegium Pharmaceutical (COLL) in Q2 2026: 21,928 shares worth $794K. The stake represents ﹤0.01% of the portfolio and ranks #922 among its holdings.

279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

Mitsubishi UFJ Trust & Banking held 21,928 shares of Collegium Pharmaceutical worth $794K as of Q2 2026.
Collegium Pharmaceutical was a new Mitsubishi UFJ Trust & Banking position in Q2 2026.
Collegium Pharmaceutical made up ﹤0.01% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #922 holding.
279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.